Skip to main content

To convert lab findings into therapies is no easy feat as there is a monumental checklist to address: safety, reproducibility, scale, and regulatory compliance. The process also has a combination of multiple vendors, and materials that were not all developed to work together.

GMP grade human platelet lysate (hPL) is the answer to this dilemma! It is manufactured in an environment that supports reproducibility, sterility, and regulatory compliance. This allows the researcher to have a xeno-free, human-derived supplement in one product with consistent levels of growth factors available for discovery and clinical use.

Researching hPL, and lab supplies into one product solves the issues of multiple reagents and validation methods. GMP hPL has undergone validation for sterility, mycoplasma, endotoxins, and viral inactivation which gives you peace of mind when utilizing it in an advanced stage with your research.

Using one trusted product from one trusted provider simplifies and consolidates your documentation. It allows labs to cite one certificate of analysis, one supplier, and one standard operating procedure. This makes everything cohesive when filing regulatory submissions and reduces the amount of back and forth regarding safety requirements.

When xeno-free, GMP hPL can service discovery, process development, and clinical production your translational pathway for the research becomes clearer, faster, and ultimately more able to support innovative therapies for patients.

Compass Biomedical
Post by Compass Biomedical
Jul 23, 2025 10:02:05 PM

Comments